NCT07156227
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more
- Locations
-
- UPMC Hillman Cancer Center LAO Pittsburgh, Pennsylvania, United States
Clinical trial condition
Unresectable Oral Cavity Squamous Cell Carcinoma
Explore clinical trials studying Unresectable Oral Cavity Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Unresectable Oral Cavity Squamous Cell Carcinoma trial results
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
NCT04576091
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States